Metraipolis › archive › dc_7cbc76d39f22

Selective serotonin reuptake inhibitors and bleeding risk in patients undergoing PCI on dual antiplatelet therapy: a retrospective cohort study — Europe PMC PMID:42138138

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42138138
DOI
10.1093/ehjcvp/pvag034
License (as archived)
solo-consultazione
Archived
2026-10-18T13:48:50.666Z
SHA-256 of the archived text
3c0e76440ce523fcc8823a7c0b8f065215384457096ff8b193e16a9e9c20272b
Stable URL of this page
https://metraipolis.com/documento/dc_7cbc76d39f22

How to cite

Selective serotonin reuptake inhibitors and bleeding risk in patients undergoing PCI on dual antiplatelet therapy: a retrospective cohort study — Europe PMC PMID:42138138 — Europe PMC (en), https://europepmc.org/article/MED/42138138 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7cbc76d39f22 (Metraipolis archive dc_7cbc76d39f22, sha256 3c0e76440ce523fcc8823a7c0b8f065215384457096ff8b193e16a9e9c20272b)
BibTeX
@misc{dc7cbc76d39f22,
  title = {Selective serotonin reuptake inhibitors and bleeding risk in patients undergoing PCI on dual antiplatelet therapy: a retrospective cohort study — Europe PMC PMID:42138138},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42138138},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7cbc76d39f22; sha256 3c0e76440ce523fcc8823a7c0b8f065215384457096ff8b193e16a9e9c20272b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42138138. Agents can read the archived copy with the MCP tool read_document.